Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Stomach Neoplasms
Interventions: BIOLOGICAL: BVAC-B
Sponsor: Cellid Co., Ltd.